BACKGROUND AND PURPOSE: The management of thrombus formation during coil
placement in an intracranial aneurysm is important in minimizing periprocedural morbidity …

BACKGROUND AND PURPOSE: Platelet-derived thrombi may occur during intracranial
aneurysm coiling. We report a series of 13 patients treated with intraarterial Abciximab for …

OBJECTIVE AND IMPORTANCE: Thromboembolic complications after cerebral aneurysm
treatment with Guglielmi detachable coils (Boston Scientific/Target, Fremont, CA) are not …

Object Experience with intraarterial abciximab for the treatment of thromboembolism during
endovascular coil embolization is limited. The authors report the outcome of intraarterial …

BACKGROUND AND PURPOSE: Experience with intravenous abciximab to manage
thromboembolism during treatment of ruptured intracranial aneurysms is limited. We present …

Introduction Thrombotic events are a common and severe complication of endovascular
aneurysm treatment with significant impact on patients' outcome. This study evaluates risk …

Background and purpose Thrombus formation during endovascular embolization of
intracranial aneurysms occurs in 2.9%–6% of patients. Use of IIb/IIIA inhibitors such as …

BACKGROUND AND PURPOSE: When using detachable coils to treat intracranial
aneurysms, thromboembolism is the most feared and frequently reported complication …

BACKGROUND: Thromboembolic complications are the most common cause of
periprocedural morbidity associated with the endovascular treatment of intracranial …

BACKGROUND AND PURPOSE: Thromboembolism is a recognized complication occurring
during endovascular coil embolization of intracranial aneurysms. Recently, there has been …